--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About IMTX20260417P10
Biological Technology
Immatics N.V., established on March 10, 2020, is a Dutch private limited liability company. The company is a biopharmaceutical company focused on the development of T-cell receptor-based immunotherapies.
